BMS-754807 T2349
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Dual IGF-1R/InsR Inhibitor BMS-754807 is an oral small molecule inhibitor of insulin-like growth factor 1 receptor (IGF-1R) and insulin receptor (InsR) tyrosine kinases with potential antineoplastic activity.
CAS nr:
1001350-96-4
Purity:
98%
Molecular Weight:
461,49
SMILES:
C[C@]1(CCCN1c1nn2cccc2c(n1)Nc1n[nH]c(c1)C1CC1)C(=O)Nc1cnc(cc1)F
Formula:
C23H24FN9O
Pathway:
Tyrosine Kinase/Adaptors,Tyrosine Kinase/Adaptors,Tyrosine Kinase/Adaptors
Target:
c-Met/HGFR,IGF-1R,Trk receptor
